Literature DB >> 8958778

Inhibitory effect of dihydrotestosterone on human thyroid cell growth.

R Rossi1, M C Zatelli, P Franceschetti, I Maestri, E Magri, G Aguiari, P Cavazzini, E C degli Uberti, L del Senno.   

Abstract

Sex steroid-binding activities have been identified by several authors in normal and pathological thyroids and the expression of the canonic androgen receptor (AR) has recently been demonstrated in human thyroid follicular cells. In order to assess what influence, if any, androgen exposure has on thyroid cell growth, the effect of dihydrotestosterone (DHT) on [3H]thymidine (thy) incorporation and cell proliferation was investigated in thyroid follicular cells in vitro. In a primary culture of goitrous cells, DHT induced a significant reduction of [3H]thy incorporation at concentrations ranging from 10(-12) to 10(-8) M, with a more pronounced effect at 10(-9) M. At this concentration, the inhibitory effect was evident after both 24 and 48 h of treatment and in various types of primary thyroid cell cultures. In goitrous cells, the DHT-induced decrease of [3H]thy was associated with a reduction of expression of the proliferation-associated nuclear Ki-67 antigen, a protein commonly used to assess cell growth fraction. In TPC cells, an AR-positive thyroid papillary carcinoma cell line, DHT at concentrations between 10(-12) and 10(-8) M significantly decreased the growth rate. DHT (10(-9) M) produced an approximately 50-60% inhibition of cell proliferation and the antiandrogen cyproterone acetate was capable of reversing such effects. The DHT-induced reduction of TPC cell proliferation was associated with a significant reduction of c-myc RNA levels. Thyroperoxidase mRNA levels and thyroglobulin production were not reduced by androgen in primary cultures of goitrous cells. In conclusion, our results indicated that androgens may have a role in this gland by reducing the proliferation, but not the function, of follicular cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958778     DOI: 10.1677/joe.0.1510185

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter?

Authors:  Alberto Gobbo; Irene Gagliardi; Andrea Gobbo; Roberta Rossi; Paola Franceschetti; Sabrina Lupo; Martina Rossi; Marta Bondanelli; Maria Rosaria Ambrosio; Maria Chiara Zatelli
Journal:  J Pers Med       Date:  2022-05-30

2.  MCM7 interacts with androgen receptor.

Authors:  Yi-Kang Shi; Yan P Yu; Ze-Hua Zhu; Yu-Chen Han; Baoguo Ren; Joel B Nelson; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

3.  Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.

Authors:  Lizamma Antony; Freek van der Schoor; Susan L Dalrymple; John T Isaacs
Journal:  Prostate       Date:  2014-06-09       Impact factor: 4.104

4.  Aberrant Expression of Androgen Receptor Associated with High Cancer Risk and Extrathyroidal Extension in Papillary Thyroid Carcinoma.

Authors:  Chen-Kai Chou; Shun-Yu Chi; Fong-Fu Chou; Shun-Chen Huang; Jia-He Wang; Chueh-Chen Chen; Hong-Yo Kang
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

5.  Androgen Signaling in Esophageal Adenocarcinoma Cell Lines In Vitro.

Authors:  Helen M Palethorpe; Paul A Drew; Eric Smith
Journal:  Dig Dis Sci       Date:  2017-10-20       Impact factor: 3.199

6.  Correlation between Insulin Resistance and Thyroid Nodule in Type 2 Diabetes Mellitus.

Authors:  Yunzhao Tang; Tiantian Yan; Gang Wang; Yijun Chen; Yanjuan Zhu; Zhenhuan Jiang; Min Yang; Chenguang Li; Zhu Li; Ping Yu; Shanshan Wang; Nannan Zhu; Qiuyue Ren; Changlin Ni
Journal:  Int J Endocrinol       Date:  2017-10-12       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.